Resolution Announcement of the Third Meeting of the Seventh Board of Directors

Jinhe Biotechnology Co., Ltd.·June 26, 2026·2 pages

✨ AI Summary

The company held its third board meeting, approving the signing of an agreement with Fama Pharmaceutical, an investment project for antibiotics and CoQ10 intermediates, and the convening of the third extraordinary general meeting. All resolutions passed unanimously.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Stock Code: 002688 Stock Abbreviation: Jinhe Bio Announcement No.: 2026-054

Jinhe Bio-Tech Co., Ltd.

Resolution Announcement of the Third Meeting of the Seventh Board of Directors

The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed in this announcement and assume joint and several liability for any false representations, misleading statements, or material omissions therein.

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.